Sort   by:  
 Page size 
UnknownMolecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial.
Not available
S-EPMC4356709 | biostudies-literature
UnknownA phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer.
Not available
S-EPMC3784336 | biostudies-literature
UnknownEfficacy and safety of bromfenac 0.09% and sodium hyaluronate 0.4% combination therapy, versus placebo in patients with pterygium I-III for clinical signs on ocular inflammation.
Not available
S-EPMC6507105 | biostudies-literature
UnknownA phase I/II trial of belinostat in combination with cisplatin, doxorubicin, and cyclophosphamide in thymic epithelial tumors: a clinical and translational study.
Not available
S-EPMC4216756 | biostudies-literature
UnknownBioengineered optogenetic model of human neuromuscular junction.
Not available
S-EPMC8439334 | biostudies-literature
UnknownLooking for Crumbs in the Obesity Forest: Anti-obesity Interventions and Obesity-Associated Cardiometabolic Traits in the Mexican Population. History and Systematic Review With Meta-Analyses.
Not available
S-EPMC8595206 | biostudies-literature
UnknownStrategic interventions in clinical randomized trials for metabolic dysfunction-associated steatotic liver disease (MASLD) and obesity in the pediatric population: a systematic review with meta-analysis and bibliometric analysis.
Not available
S-EPMC11580631 | biostudies-literature
Unknown3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma.
Not available
S-EPMC10121654 | biostudies-literature
UnknownCircular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastoma.
Not available
S-EPMC10703696 | biostudies-literature
UnknownControl of paratuberculosis: who, why and how. A review of 48 countries.
Not available
S-EPMC6567393 | biostudies-literature
Sort   by:  
 Page size